Smart Phones to be used by assisTek to Collect Patient-Reported Outcomes in a Large Multinational Clinical Trial

Share Article

assisTek, the Leader in Innovative Electronic Patient Reported Outcomes (ePRO) Solutions and Patient Questionnaires for Clinical Trials announced that it has been awarded a contract to use their state-of-the-art smart phone technology to collect data from patients at home on electronic diaries in an upcoming large multi-national clinical trial.

Smart Phone for ePRO clinical trials

We look forward to providing our clinical trial participants with this capability. Participating in a clinical trial is a significant time commitment for patients, stated Dr. Temitayo Ajayi, Medical Director for PTC Therapeutics.

assisTek, the Leader in Innovative Electronic Patient Reported Outcomes (ePRO) Solutions and Patient Questionnaires for Clinical Trials announced that it has been awarded a contract to use their state-of-the-art smart phone technology to collect data from patients at home on electronic diaries in an upcoming large multi-national clinical trial.

The smart phone chosen for the trial will be an HTC Fuze, which looks similar to Apple iPhone. It provides significant advantages over past electronic diary solutions based on Palm technology.

Palm-based devices require patients to install, implement, and use a modem interface in their home on a daily basis to transfer the data from the device to a central data repository. Because patients participating in clinical trials often have significant other challenges, this requirement can be difficult and time consuming for all clinical trial participants -- the patients, clinicians, and technology vendors.

Benefits:

  • assisTek's smart phone product, the MobilePRO eliminates much of the work and hassle associated with Palm devices.
  • The smart phone transfers data automatically through cell phone networks using the SIM card inside the phone.
  • This technological breakthrough will save countless hours of work in clinical trial data collection.

"We are very proud to lead the industry in providing innovative electronic diary solutions to collect data from patients in clinical trials," said Joy Hebert, Chief Executive Officer of assisTek. "We introduced the collection of patient reported outcomes on Apple iPhones and internet platforms last year, and are proud to now deliver this new breakthrough product this year."

Not only does this technology significantly reduce the work and hassle factor in collecting data from patients, it is also a beautiful product. It includes striking colors and photos not available in the older technologies offered by other vendors.

"We look forward to providing our clinical trial participants with this capability. Participating in a clinical trial is a significant time commitment for patients, stated Dr. Temitayo Ajayi, Medical Director for PTC Therapeutics. "We believe it is beneficial to utilize state of the art technology, such as the assisTek Smart Phones to minimize the reporting burden and potentially increase compliance utilizing accessible technologies."

For more information about assisTek's ePRO systems or to schedule a free no-obligation demonstration, contact assisTek.

About assisTek
assisTek is the global leader in ePRO systems and has revolutionized the process of collecting patient-reported outcomes in clinical trials by helping sites collect the data electronically through innovation, using touch-screens tablets, internet, Apple iPhones, and other smart phones.

The assisTek team has more than 45,000 patients in more than 35 therapeutic areas at more than 4,500 sites across 5 continents. Visit assisTek online.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Joy Hebert
assisTek
480-874-9400 ext. 318
Email >
Visit website